Eric Lefkofsky’s Foundation And Other Charitable Work

Eric Lefkofsky has made a lot of money. He has founded five different companies and is currently serving as the CEO of Groupon. In a recent interview, he talked openly about money. He said that life was difficult starting his first company as he worried about paying the bills. Now, he is flush with cash and focuses on giving much of it away. After all, he has too much money to spend by himself.

That’s why the businessman has turned philanthropist. In 2006, Eric and his wife put together a charitable trust. It’s fittingly called the Lefkofsky Foundation and focuses its energy on helping children. The mission statement says that the charitable trust has been put together in order to support scientific, charitable and educational organizations around the world. The trust has helped fund more than 50 worldwide organizations.

The charitable trust really zeros in on education. It focuses on the middle grades so that it can help children at a critical developmental age. It also endeavors to improve the rights of girls and women across the planet. And money from the charitable organization focuses on underserved communities in order to improve human rights regardless of gender.

The organization also focuses on medical research. For example, the trust has funded the American Brain Tumor Association which is the first national charitable organization focusing solely on brain tumors. The organization has been doing good work for 40 years and the Lefkofsky Foundation has honored that work with well-needed funding. The ABTA focuses on all aspects of brain cancer including diagnosis, treatment and care. Its mission is to eradicate brain cancer from the planet while alleviating the suffering of those who have already been diagnosed.

Eric Lefkofsky himself has co-founded a company called Tempus. The technology company focuses on genetic sequencing in order to come up with innovative ways to diagnose, treat and perhaps cure various cancers. Cancer is a difficult disease because it is genetically different for each individual patient. Lefkofsky is now using his knowledge of technology to further cancer research on an individual level using genetics and other technologies.